Synthesis of nanomedicines by nanohybrids conjugating ginsenosides with auto-targeting and enhanced MRI contrast for liver cancer therapy

References

• Zhou B, Yan Z, Liu R, et al. Prospective study of transcatheter arterial chemoembolization (TACE) with ginsenoside Rg3 versus TACE alone for the treatment of patients with advanced hepatocellular carcinoma. Radiology. 2016;280:630.
   PubMed Web of Science ®Google Scholar
• Kim D, Jung K, Lee D, et al. 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin. Oncotarget. 2014;5:4438–4451.
   PubMedGoogle Scholar
• Stewart B, Wild CP. World Cancer Report 2014. International Agency for Research on Cancer WHO. 2014.
   Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer Statistics in China, 2015. Ca Cancer J Clin. 2016;6:15–132.
   Google Scholar
• Breitbach C, Moon A, Burke J, et al. A phase 2, open-label, randomized study of Pexa-Vec (JX-594) administered by intratumoral injection in patients with unresectable primary hepatocellular carcinoma. Methods Mol Biol. 2015;1317:343–357.
   PubMedGoogle Scholar
• Jiang J, Chen X, Chen X, et al. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway. World J Gastroenterol. 2011;17:3174–3181.
   Web of Science ®Google Scholar
• Teowab Y, Valiyaveettil S. Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles. Nanoscale. 2012;2:2607–2613.
   Web of Science ®Google Scholar
• Bhattacharyya S, Kudgus RA, Bhattacharya R, et al. Inorganic nanoparticles in cancer therapy. Pharm Res. 2011;28:237–259.
   PubMed Web of Science ®Google Scholar
• Bogart LK, Pourroy G, Murphy CJ, et al. Nanoparticles for imaging, sensing, and therapeutic intervention. ACS Nano. 2014;8:3107–3122.
   PubMed Web of Science ®Google Scholar
• Lee N, Yoo D, Ling D, et al. Iron oxide based nanoparticles for multimodal imaging and magnetoresponsive therapy. Chem Rev. 2015;115:10637–10689.
   PubMed Web of Science ®Google Scholar
• Perez-Quintanilla D, Gomez-Ruiz S, Zeljko Z, et al. A new generation of anticancer drugs: mesoporous materials modified with titanocene complexes. Chem Eur J. 2009;15:5588–5597.
   PubMed Web of Science ®Google Scholar
• Gao J, Gu H, Xu B. Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc Chem Res. 2009;42:1097–1107.
   PubMed Web of Science ®Google Scholar
• Laprise-Pelletier M, Lagueux J, Côté M-F, et al. Low-dose prostate cancer brachytherapy with radioactive palladium–gold nanoparticles. Adv Healthcare Mater. 2017;6:1601120.
   Web of Science ®Google Scholar
• Manshian BB, Jimenez J, Himmelreich U, et al. Presence of an immune system increases anti-tumor effect of Ag nanoparticle treated mice. Adv Healthcare Mater. 2017;6:1601099.
   Web of Science ®Google Scholar
• Peng H, Tang J, Zheng R, et al. Nuclear-targeted multifunctional magnetic nanoparticles for photothermal therapy. Adv Healthcare Mater. 2017;6:1601289.
   Web of Science ®Google Scholar
• D'Mello SR, Cruz CN, Chen M-L, Kapoor M, Lee SL, Tyne KM. The evolving landscape of drug products containing nanomaterials in the United States. Nat Nanotechnol. 2017;12:523–529.
   PubMed Web of Science ®Google Scholar
• Asharani PV, Sethu S, Vadukumpully S, et al. Investigations on the structural damage in human erythrocytes exposed to silver, gold, and platinum nanoparticles. Adv Funct Mater. 2010;20:1233–1242.
   Web of Science ®Google Scholar
• Cole LE, Ross RD, Tilley JM, et al. Gold nanoparticles as contrast agents in X-ray imaging and computed tomography. Nanomedicine (Lond.). 2015;10:321–341.
   PubMed Web of Science ®Google Scholar
• Gao J, Liang G, Zhang B, et al. FePt@CoS2Yolk-Shell nanocrystals as a potent agent to kill HeLa cells. J Am Chem Soc. 2009;129:1428–1433.
   Web of Science ®Google Scholar
• Gao J, Xu B. Applications of nanomaterials inside cells. Nano Today. 2009;4:37–51.
   Web of Science ®Google Scholar
• Lee N, Cho HR, Hwan M, et al. Multifunctional Fe3O4/TaOx core/shell nanoparticles for simultaneous magnetic resonance imaging and X-ray computed tomography. J Am Chem Soc. 2012;134:10309–10312.
   PubMed Web of Science ®Google Scholar
• López-Alonso J, Diez-Garcia F, Font J, et al. Carbodiimide EDC induces cross-links that stabilize RNase A C-dimer against dissociation: EDC adducts can affect protein net charge, conformation and activity. Bioconjugate Chem. 2009;20:1459–1473.
   PubMed Web of Science ®Google Scholar
• Halloran MJ, Parker CW. The preparation of nucleotide-protein conjugates: carbodiimides as coupling agents. J Immunol. 1996;96:373–378.
   Google Scholar
• Valeur E, Bradley M. Amide bond formation: beyond the myth of coupling reagents. Chem Soc Rev. 2009;38:606–631.
   PubMed Web of Science ®Google Scholar
• Leitner A, Joachimiak LA, Unverdorben P, et al. Chemical cross-linking/mass spectrometry targeting acidic residues in proteins and protein complexes. Proc Natl Acad Sci. 2014;111:9455–9460.
   PubMed Web of Science ®Google Scholar
• Głuszyńska A. Biological potential of carbazole derivatives. Eur J Med Chem. 2015;94:405–426.
   PubMed Web of Science ®Google Scholar
• Manickam M, Belloni M, Kumar S, et al. The first hexagonal columnar discotic liquid crystalline carbazole derivatives induced by noncovalent π-π interactions. J Mater Chem. 2001;11:2790–2800.
   Web of Science ®Google Scholar
• Wong SS. CRC chemistry of protein conjugation and crosslinking. In Wong SS, editor. CRC Press: Boca Raton Florida, 1991;7–45.
   Google Scholar
• Minhong J, Sanghoon L, Jae K, et al. Physical limits of pure superparamagnetic Fe3O4 nanoparticles for a local hyperthermia agent in nanomedicine. Appl Phys Lett. 2012;100:092406.
   Web of Science ®Google Scholar
• Hu B, Wang S, Du Q. Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: from bench to bedside. World J Hepatol. 2015;7:1209–1232.
   PubMedGoogle Scholar
• Weaver BA. How Taxol/paclitaxel kills cancer cells. Mol Biol Cell. 2014;25:2677–2681.
   PubMed Web of Science ®Google Scholar
• Ibrahim NK, Desai N, Legha S, et al. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res. 2002;8:1038–1044.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. FDA approval for paclitaxel albumin-stabilized nanoparticleformulation. Available from: https://www.cancer.gov/about-cancer/treatment/drugs/fda-nanoparticle-paclitaxel 2013.
   Google Scholar
• Lee J, Jung K, Morgan M, et al. Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells. Mol Cancer Ther. 2013;12:274–285.
   PubMed Web of Science ®Google Scholar
• Jiang J, Chen X, Chen X, et al. Ginsenoside Rg3 inhibit hepatocellular carcinoma growth via intrinsic apoptotic pathway. World J Gastroenterol. 2011;17:3605–3613.
   PubMed Web of Science ®Google Scholar
• He F, Su X-L, Lu M-m, et al. Comparative pharmacokinetics of ginsenoside Rg3 and ginsenoside Rh2 after oral administration of ginsenoside Rg3 in normal and walker 256 tumor-bearing Rats. Phcog Mag. 2016;12:21–24.
   Google Scholar
• Wang H, Zou H, Kong L, et al. Determination of ginsenoside Rg3 in plasma by solid-phase extraction and high-performance liquid chromatography for pharmacokinetic study. J Chromatogr B Biomed Sci Appl. 1999;731:403–409.
   PubMedGoogle Scholar
• Naldini L. Gene therapy returns to centre stage. Nature. 2015;526:351–360.
   PubMed Web of Science ®Google Scholar
• Galanti M, Fanelli D, Piazza F. Conformation-controlled binding kinetics of antibodies. Sci Rep. 2016;6:18976.
   PubMed Web of Science ®Google Scholar
• Gerdesa MJ, Sevinsky CJ, Sood A. Highly multiplexed single-cell analysis of formalinfixed, paraffin-embedded cancer tissue. PNAS. 2013;110:11982–11987.
   PubMed Web of Science ®Google Scholar
• Song Y, Wang R, Rong R, et al. Synthesis of well-dispersed aqueous-phase magnetite nanoparticles and their metabolism as MRI contrast agent for reticuloendothelial system. Eur J Inorg Chem. 2011;22:3303–3313.
   Google Scholar
• Wang J, Zhao K, Shen X, et al. Microfluidic synthesis of ultra-small magnetic nanohybrids for enhanced magnetic resonance imaging. J Mater Chem C. 2015;3:12418–12429.
   Web of Science ®Google Scholar
• Huang X, El-Sayed IH, Qian W, et al. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc. 2006;128:2115–2120.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li Z, Wang H, et al. IR-780 loaded phospholipid mimicking homopolymeric micelles for near-ir imaging and photothermal therapy of pancreatic cancer. ACS Appl Mater Interfaces. 2016;8:6852–6858.
   PubMed Web of Science ®Google Scholar
• Gao Z, Liu X, Wang Y, et al. Facile one-pot synthesis of Fe3O4@chitosan nanospheres for MRI and fluorescence imaging guided chemo-photothermal combinational cancer therapy. Dalton Trans. 2016;45:19519–19528.
   PubMed Web of Science ®Google Scholar
• Salarizadeh P, Javanbakht M, Pourmahdian S, et al. Surface modification of Fe2TiO5 nanoparticles by silane coupling agent: synthesis and application in proton exchange composite membranes. J Colloid Interface Sci. 2016;472:135–144.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Z, Li S, Wang R, Song Y. Surface and interface engineering of FePt/C nanocatalysts for electro-catalytic methanol oxidation: enhanced activity and durability. Nanoscale. 2017;9:4066–4075.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhao H, Zhu Y, Song Y. Shape-controlled synthesis of CdSe nanocrystals via a programmed microfluidic process. J Phys Chem C. 2017;121:3567–3572.
   Web of Science ®Google Scholar
• Song Y, Ji S, Song Y-J, et al. In-situ redox microfluidic synthesis of core-shell nanoparticles and their long-term stability. J Phys Chem C. 2013;117:17274–17284.
   Web of Science ®Google Scholar
• Shen Y, Posavec L, Bolisetty S, et al. Amyloidfibril systems reduce, stabilize and deliver bioavailable nanosized iron. Nat Nanotechnol. 2017;12:642–647.
   PubMed Web of Science ®Google Scholar
• Min Y, Kyle CR, Tian S, et al. Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy. Nat Nanotechnol. 2017;12:877–882.
   PubMed Web of Science ®Google Scholar
• Chou P-H, Chen S-H, Liao H-K, et al. Nanoprobe-based affinity mass spectrometry for selected protein profiling in human plasma. Anal Chem. 2005;77:5990–5997.
   PubMed Web of Science ®Google Scholar
• Kim HS, Kye YS, Hage DS. Development and evaluation of N-hydroxysuccinimide-activated silica for immobilizing human serum albumin in liquid chromatography columns. J Chromatogr A. 2004;1049:51–61.
   PubMed Web of Science ®Google Scholar
• Yin S, Chen X, Hu C, et al. Nanosecond pulsed electric field (nsPEF) treatment for hepatocellular carcinoma: a novel locoregional ablation decreasing lung metastasis. Cancer Lett. 2014;346:285–291.
   PubMed Web of Science ®Google Scholar
• Song Y, Liu F, Sun B. Preparation, characterization, and application of thin film composite nanofiltration membranes. J Appl Polym Sci. 2005;95:1251–1256.
   Web of Science ®Google Scholar
• (a) Infrared spectra library – FTIR Library. NICODOM Copyright NICODOM. 2009. Available from: http://www.infrared-spectra.com/. (b) Yun X. Infrared absorption spectrum characteristic peak. 2011. Available from: https://wenku.baidu.com/view/4a88911b964bcf84b9d57bcd.html. (c) Zhou L. The infrared absorption peak characteristics of functional groups. 2015. Available from: https://wenku.baidu.com/view/1a6ef061f90f76c660371a48.html.
   Google Scholar
• Griffiths PR, de Haseth JA. Fourier transform infrared spectrometry. 2nd ed. Hoboken (NJ); Canada: John Wiley & Sons; 2007.
   Google Scholar
• Song W. Study of the IR characteristic peaks of wild Ginsengs with FT-IR spectroscopy (in Chinese). J TianJin Norm Univ (Nat Sci Ed). 2009;29:63–65.
   Google Scholar